Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company is headquartered in Tianjin, Tianjin and currently employs 86 full-time employees. The company went IPO on 2006-05-23. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is used as a medical device that accelerates bone healing. The firm distributes its medical devices to hospitals as well as other medical device customers that are not hospitals. The firm mainly conducts its business in the domestic market.
Follow-Up Questions
Genex Pharmaceutical Inc (GENX)의 PER은 얼마입니까?
Genex Pharmaceutical Inc의 PER은 0.0009입니다
Genex Pharmaceutical Inc의 CEO는 누구입니까?
Song Fuzhi은 2004부터 회사에 합류한 Genex Pharmaceutical Inc의 Chairman of the Board입니다.
GENX 주식의 가격 성능은 어떻습니까?
GENX의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Genex Pharmaceutical Inc의 주요 사업 주제나 업종은 무엇입니까?
Genex Pharmaceutical Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
